Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03778827 · ClinicalTrials.gov registry record · NA
A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism
A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT03778827: Active NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
NCT03778827 is a NA study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 75 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03778827, a NA study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
Conditions Studied
Interventions
- BEHAVIORAL Intensive Center-Based Pivotal Response Treatment (PRT-C)
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT03778827 still lists
NCT03778827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Intensive Center-Based Pivotal Response Treatment (PRT-C) is the first listed.
NCT03778827 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03778827 about?
NCT03778827 is a clinical study titled "A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism". The purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
What is the current status of trial NCT03778827?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2019-05-13. Estimated completion is 2026-06.
What conditions does trial NCT03778827 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.
What interventions are being tested in trial NCT03778827?
The interventions under investigation include: Intensive Center-Based Pivotal Response Treatment (PRT-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03778827?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03778827 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03778827's enrollment target sits among peer trials
75 100th of 224 higher than 122 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI